Catalyst Pharmaceuticals
CPRX
#4039
Rank
HK$23.47 B
Marketcap
HK$190.96
Share price
2.22%
Change (1 day)
7.70%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: HK$23.47 Billion

As of February 2026 Catalyst Pharmaceuticals has a market cap of HK$23.47 Billion. This makes Catalyst Pharmaceuticals the world's 4039th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$23.47 B0.79%
2025HK$23.28 B17.13%
2024HK$19.88 B42.04%
2023HK$13.99 B-7.46%
2022HK$15.12 B178.18%
2021HK$5.43 B102.33%
2020HK$2.68 B-11.01%
2019HK$3.01 B95.49%
2018HK$1.54 B-50.66%
2017HK$3.13 B363.79%
2016HK$0.67 B-57.1%
2015HK$1.57 B-1.19%
2014HK$1.59 B94.53%
2013HK$0.81 B486.09%
2012HK$0.13 B-43.57%
2011HK$0.24 B65.63%
2010HK$0.14 B69.58%
2009HK$88.11 M-54.95%
2008HK$0.19 B-41.96%
2007HK$0.33 B-28.33%
2006HK$0.47 B

End of Day market cap according to different sources

On Feb 8th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

HK$23.47 Billion
by Nasdaq info icon info icon
HK$23.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.517 T 19,148.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.209 T 5,052.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.507 T 6,321.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$15.14 B-35.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.41 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$87.25 B 271.76%๐Ÿ‡บ๐Ÿ‡ธ USA